Search clinical trials for: SYREBO

Total 20 results

Hasanuddin University

Not yet recruiting

Robotic Versus Conventional Therapy For Post-Stroke Hand Motoric Recovery

Stroke | Physical Disability | Upper Extremity Paresis

Indonesia
Bioscan Research Pvt. Ltd.

Not yet recruiting

Usability Study of CEREBO® - A Novel Non-invasive Intracranial Bleed Detector

Traumatic Brain Injury | Intracranial Hemorrhages
Bioscan Research Pvt. Ltd.

Not yet recruiting

Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector

Usability
National Institute of Mental Health and Neuro Sciences...

Completed

Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection

Traumatic Brain Injury

India
Nutricia Nutrition Clinique

Completed

Interest of Peticate Syneo Infant Formula in Children Allergic to Cow's Milk Protein: Real Life Study (PEPSY)

Milk Hypersensitivity

France
Nutricia Nutrition Clinique

Not yet recruiting

Observatory on Cow's Milk Protein Allergy (OLAF)

Food Allergy

France
Kessler Foundation
Saebo, Inc.

Completed

Saeboflex Dynamic Hand Orthosis for Inpatient Rehabilitation Stroke Patients

Stroke

United States
Kessler Foundation
Saebo, Inc.

Completed

A Pilot Study Investigating the Feasibility of the Saebo Arm Training Program on an Inpatient Population

Stroke | Hemiplegia

United States
Emory University
Teva Pharmaceuticals USA

Terminated

Omacetaxine for Consolidation and Maintenance

Acute Myelogenous Leukemia (AML)

United States
M.D. Anderson Cancer Center
Teva Pharmaceuticals USA

Completed

Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure

Leukemia

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Chronic Myeloid Leukemia

United States, Belgium, France, Korea, Republic of
Teva Branded Pharmaceutical Products R&D, Inc.
Cephalon; ChemGenex Pharmaceuticals

Completed

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Chronic Myeloid Leukemia

United States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
M.D. Anderson Cancer Center
Teva Pharmaceuticals USA

Terminated

Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Leukemia

United States
University of Florida
Teva Pharmaceutical Industries, Ltd.

Withdrawn

A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United States
University of Pisa

Completed

Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole

Graves' Disease

Italy
CHU de Reims

Terminated

Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox) (ORTHOX)

Upper Limb Spasticity

France
M.D. Anderson Cancer Center

Active, not recruiting

Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1

Hematopoietic and Lymphoid Cell Neoplasm | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma | Stage IVA Oropharyngeal Carcinoma AJCC v7 | Stage IVB Oropharyngeal Carcinoma AJCC v7

United States

Search clinical trials for: SYREBO

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations